Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.

@article{Stephans2014EsophagealDT,
  title={Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.},
  author={Kevin L. Stephans and Toufik Djemil and Claudiu I Diaconu and Chandana A. Reddy and Ping Xia and Neil M. Woody and John F. Greskovich and Vinit Makkar and Gregory M. M. Videtic},
  journal={International journal of radiation oncology, biology, physics},
  year={2014},
  volume={90 1},
  pages={
          197-202
        }
}
PURPOSE To identify factors associated with grade ≥3 treatment related late esophageal toxicity after lung or liver stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS This was a retrospective review of 52 patients with a planning target volume within 2 cm of the esophagus from a prospective registry of 607 lung and liver SBRT patients treated between 2005 and 2011. Patients were treated using a risk-adapted dose regimen to a median dose of 50 Gy in 5 fractions (range, 37.5-60… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

An RNA-seq-Based Expression Profiling of Radiation-Induced Esophageal Injury in a Rat Model

VIEW 1 EXCERPT
CITES BACKGROUND

Risk-adapted stereotactic ablative radiotherapy for central and ultra-central lung tumours.

Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.

VIEW 1 EXCERPT
CITES BACKGROUND